medigraphic.com
ISSN 1729-519X (Print)

2016, Number 2

<< Back Next >>

Revista Habanera de Ciencias Médicas 2016; 15 (2)

Use of spirulin in pregnant woman with heterozygous minor beta-thalassemia. A case report

Quiñones MMV, Campos RR, Gil LE

Language: Spanish
References: 11
Page: 186-191
PDF size: 98.94 Kb.


ABSTRACT

Introduction: The hemoglobin is a protein tetrameric carrier of oxygen to the cells and tissues of the body, composed by four subunits: two α-Globin sub units and two of β-Globin (α-2, β-2), most of individuals heterozygote β+/β or βo/β) They are silent carries that do not manifest symptoms (β thalassemia minor) sometimes, can present mild anemia episode.
Objective: Present a case of pregnant with heterozygoteβ thalassemia minor enhancing the efficiency of the supplement Spirel.
Case presentation: A Pregnant woman resident in Mayabeque Province, with antecedents of heterozygote β thalassemia minor with treatment of folic acid , in a previous pregnancy received 13 transfusions keeping hemoglobin of 3 to 4g/l). To the 23,5 weeks. Once received the first therapy transfusion are given 3 pills 30 minutes after breakfast, lunch and dinner of Spirel containing Spirulin Platensis (Sp), proteins, vitamins, and other compounds with 16 g of chelate iron.
Conclusions: The presentation of this case remarks the efficacy of the Spirel supplement according to hemoglobin, maternal weight, uterine height, and the newborn weight, in pregnant with a diagnosis of β thalassemia minor.


REFERENCES

  1. De Baun, MR. Frei-Jones, M. Vishinski, E. Hemoglobinopathies. In: Kliegman, RM. Behrman, RE. Jenson, HB. Stanton, BF eds. Nelson Textbook of Pediatrics.Philadelphia, Pa: Saunders Elsevier; 2011, chap 456.

  2. Sociedad Argentina de Hematología .De Hematología: Guías de Diagnóstico y Tratamiento. 2015, t.1.

  3. Steimberg M. Disorders of hemoglobin: genetics, pathophysiology and clinical management. Cambridge University Press; 2001, p.1235.

  4. MedlinePlus enciclopedia médica. Página actualizada: 08 septiembre 2014.

  5. Maldonado Barrueco A, San Román Salmador B. Sobrecarga de hierro en la β- talasemia: Una revisión de los antiguos y nuevos quelantes con aplicación clínica. REDUCA. 2014; 6(1).

  6. Rasool M. Sabina EP. Appraisal of immunomodulatory potential of Spirulina fusiformis: an in vivo and in vitro study. J Nat Med. 2009; 63(2):169-175.

  7. Acosta Karina B. Estudio de las mutaciones CD39 e IVS1-110 causantes de β- talasemia mediante ARMS-PCR. Rev. cienc. tecnol. [online]. 2010;(14). [Citado 2015-09-10] . Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851- 75872010000200006&lng=es&nrm=iso ISSN 1851-7587

  8. Ohene-Frempong, K. Schwartz, E. Clinical features of thalassemia. In Pediat. Clin. N.A. 1980; 27:403-410.

  9. Zouari N, Abid M, Fakhfakh N, Ayadi MA, Lazhar Z, Ayadi M, Attia H. Blue-green algae (Arthrospira platensis) as an ingredient in pasta: free radical scavenging activity, sensory and cooking characteristics evaluation. Int J Food Sci and Nutr. 2011; 62(8): 811-813.

  10. Christaki E, Florou-Paneri P, Bonos E. Microalgae: a novel ingredient in nutrition. Int J Food Sci and Nutr. 2011; 62(8):794-799.

  11. Heredero L. Un programa de genética en un país en desarrollo: Cuba. Bol Of Sanit 1993; 115(1):32-8.




2020     |     www.medigraphic.com